Gyroscope Therapeutics



Gyroscope Therapeutics is a clinical-stage retinal gene therapy company developing gene therapy beyond rare diseases to treat a leading cause of blindness, dry age-related macular degeneration (AMD).

Khurem Farooq
CEO & Board Member
Khurem Farooq
Edward Lang Jr
Chief Business Officer
Ian Pitfield
SVP, Technical Operations
Jane Hughes
Chief Scientific Officer
Nadia Waheed
Chief Medical Officer
Jessica Stitt
Chief Financial Officer
Ingrid Boyes
Chief People Officer
Elaine Johnston
General Counsel

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.